Clinical Trial Update: Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant thyrotropin–PET-CT fusion scanning in thyroid cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Johns Hopkins University | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-11-02